# Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy

> **NCT00329797** · PHASE3 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 109 (actual)

## Conditions studied

- Osteoporosis
- Prostate Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Calcium
- **DIETARY_SUPPLEMENT:** Zoledronic acid
- **RADIATION:** radiation therapy
- **DRUG:** LHRH
- **DIETARY_SUPPLEMENT:** Vitamin D

## Key facts

- **NCT ID:** NCT00329797
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2017-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00329797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00329797, "Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00329797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*